INT227660

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.23
First Reported 2003
Last Reported 2008
Negated 1
Speculated 0
Reported most in Body
Documents 2
Total Number 6
Disease Relevance 3.81
Pain Relevance 1.57

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

lysosome (IDS)
Anatomy Link Frequency
muscle 2
IDS (Homo sapiens)
Pain Link Frequency Relevance Heat
Angina 215 93.20 High High
imagery 106 23.36 Low Low
adenocard 15 5.00 Very Low Very Low Very Low
tolerance 15 5.00 Very Low Very Low Very Low
Pain 10 5.00 Very Low Very Low Very Low
depression 5 5.00 Very Low Very Low Very Low
abdominal pain 5 5.00 Very Low Very Low Very Low
agonist 5 5.00 Very Low Very Low Very Low
Inflammation 2 5.00 Very Low Very Low Very Low
cytokine 1 5.00 Very Low Very Low Very Low
Disease Link Frequency Relevance Heat
Syndrome 30 93.60 High High
Angina 140 93.20 High High
Coronary Artery Disease 225 91.68 High High
Stress 175 73.52 Quite High
Rheumatoid Arthritis 8 50.12 Quite High
Disease 80 26.92 Quite Low
Myocardial Infarction 120 5.00 Very Low Very Low Very Low
Cv General 3 Under Development 80 5.00 Very Low Very Low Very Low
Acute Coronary Syndrome 75 5.00 Very Low Very Low Very Low
Cv Unclassified Under Development 75 5.00 Very Low Very Low Very Low

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
If there is a perception of underutilisation of MPS in the UK, how should correct usage be judged?
Negative_regulation (perception) of Localization (underutilisation) of MPS
1) Confidence 0.23 Published 2003 Journal Eur J Nucl Med Mol Imaging Section Body Doc Link PMC2562441 Disease Relevance 0 Pain Relevance 0
MPS, Regular user of MPS; non-MPS, occasional user of MPS. [252]
Negative_regulation (user) of Localization (user) of MPS
2) Confidence 0.23 Published 2003 Journal Eur J Nucl Med Mol Imaging Section Body Doc Link PMC2562441 Disease Relevance 0.94 Pain Relevance 0.39
MPS, Regular user of MPS; non-MPS, occasional user of MPS. [252]
Negative_regulation (user) of Localization (user) of MPS
3) Confidence 0.23 Published 2003 Journal Eur J Nucl Med Mol Imaging Section Body Doc Link PMC2562441 Disease Relevance 0.94 Pain Relevance 0.39
MPS, Regular user of MPS; non-MPS, occasional user of MPS. [252]
Negative_regulation (user) of Localization (user) of MPS
4) Confidence 0.23 Published 2003 Journal Eur J Nucl Med Mol Imaging Section Body Doc Link PMC2562441 Disease Relevance 0.94 Pain Relevance 0.39
MPS, Regular user of MPS; non-MPS, occasional user of MPS. [252]
Negative_regulation (user) of Localization (user) of MPS
5) Confidence 0.23 Published 2003 Journal Eur J Nucl Med Mol Imaging Section Body Doc Link PMC2562441 Disease Relevance 0.94 Pain Relevance 0.39
The rate of MPS in relation to muscle RNA concentration, a measure of the translational efficiency in muscle, was not different between men and women during basal, postabsorptive conditions (0.012±0.003 vs. 0.013±0.002 mg protein·µg RNA?
Neg (not) Negative_regulation (different) of Localization (relation) of MPS in muscle
6) Confidence 0.04 Published 2008 Journal PLoS ONE Section Body Doc Link PMC2267222 Disease Relevance 0.05 Pain Relevance 0

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox